A carregar...
Deferasirox for managing iron overload in people with myelodysplastic syndrome
BACKGROUND: The myelodysplastic syndrome (MDS) comprises a diverse group of haematopoietic stem cell disorders. Due to symptomatic anaemia, most people with MDS require supportive therapy including repeated red blood cell (RBC) transfusions. In combination with increased iron absorption, this contri...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2014
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7202239/ https://ncbi.nlm.nih.gov/pubmed/25348770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007461.pub3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|